141 related articles for article (PubMed ID: 36397092)
1. Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC population.
Petria I; Albuquerque S; Varoquaux G; Vie JJ; Venteclef N; Mohammedi K; Roussel R; Camoin M; Perseghin G; Velho G; Potier L
Cardiovasc Diabetol; 2022 Nov; 21(1):247. PubMed ID: 36397092
[TBL] [Abstract][Full Text] [Related]
2. The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes: The DCCT/EDIC Trials.
Budoff M; Backlund JC; Bluemke DA; Polak J; Bebu I; Schade D; Strowig S; Raskin P; Lachin JM;
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 2):1341-1349. PubMed ID: 30878435
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study.
Bebu I; Schade D; Braffett B; Kosiborod M; Lopes-Virella M; Soliman EZ; Herman WH; Bluemke DA; Wallia A; Orchard T; Lachin JM;
Diabetes Care; 2020 Apr; 43(4):867-874. PubMed ID: 32001614
[TBL] [Abstract][Full Text] [Related]
4. Genetic Risk Factors for CVD in Type 1 Diabetes: The DCCT/EDIC Study.
Bebu I; Keshavarzi S; Gao X; Braffett BH; Canty AJ; Herman WH; Orchard TJ; Dagogo-Jack S; Nathan DM; Lachin JM; Paterson AD;
Diabetes Care; 2021 Jun; 44(6):1309-1316. PubMed ID: 33883194
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Pop-Busui R; Braffett BH; Zinman B; Martin C; White NH; Herman WH; Genuth S; Gubitosi-Klug R;
Diabetes Care; 2017 Jan; 40(1):94-100. PubMed ID: 27803120
[TBL] [Abstract][Full Text] [Related]
6. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up.
Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group
Diabetes Care; 2016 May; 39(5):686-93. PubMed ID: 26861924
[TBL] [Abstract][Full Text] [Related]
7. Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes.
Gubitosi-Klug R; Gao X; Pop-Busui R; de Boer IH; White N; Aiello LP; Miller R; Palmer J; Tamborlane W; Wallia A; Kosiborod M; Lachin JM; Bebu I;
Diabetes Care; 2021 Jul; 44(7):1499-1505. PubMed ID: 33980605
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Plasma Kallikrein Levels and Their Association With the Risk of Cardiovascular Disease Outcomes in Type 1 Diabetes in DCCT/EDIC.
Jaffa MA; Bebu I; Luttrell D; Braffett BH; Lachin JM; Hunt K; Lopes-Virella M; Luttrell L; Lyons TJ; Jaffa AA;
Diabetes; 2020 Nov; 69(11):2440-2445. PubMed ID: 32826295
[TBL] [Abstract][Full Text] [Related]
9. Risk factor variability and cardiovascular risk among patients with diabetes: a nationwide observational study.
Ceriello A; Lucisano G; Prattichizzo F; La Grotta R; Franzén S; Gudbjörnsdottir S; Eliasson B; Nicolucci A
Eur J Prev Cardiol; 2023 Jun; 30(8):719-727. PubMed ID: 36897149
[TBL] [Abstract][Full Text] [Related]
10. Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus.
Bangalore S; Fayyad R; DeMicco DA; Colhoun HM; Waters DD
Circ Cardiovasc Qual Outcomes; 2018 Nov; 11(11):e004724. PubMed ID: 30571333
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study.
Keshavarzi S; Braffett BH; Pop-Busui R; Orchard TJ; Soliman EZ; Lorenzi GM; Barnie A; Karger AB; Gubitosi-Klug RA; Dagogo-Jack S; Paterson AD;
Diabetes Care; 2021 May; 44(5):1125-1132. PubMed ID: 33632724
[TBL] [Abstract][Full Text] [Related]
12. Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Purnell JQ; Braffett BH; Zinman B; Gubitosi-Klug RA; Sivitz W; Bantle JP; Ziegler G; Cleary PA; Brunzell JD;
Diabetes Care; 2017 Dec; 40(12):1756-1762. PubMed ID: 29138273
[TBL] [Abstract][Full Text] [Related]
13. Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus.
Sousa GR; Pober D; Galderisi A; Lv H; Yu L; Pereira AC; Doria A; Kosiborod M; Lipes MA
Circulation; 2019 Feb; 139(6):730-743. PubMed ID: 30586738
[TBL] [Abstract][Full Text] [Related]
14. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
Purnell JQ; Zinman B; Brunzell JD;
Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
[TBL] [Abstract][Full Text] [Related]
15. Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial.
Verma S; Bain SC; Buse JB; Idorn T; Rasmussen S; Ørsted DD; Nauck MA
JAMA Cardiol; 2019 Dec; 4(12):1214-1220. PubMed ID: 31721979
[TBL] [Abstract][Full Text] [Related]
16. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
Lachin JM; Orchard TJ; Nathan DM;
Diabetes Care; 2014; 37(1):39-43. PubMed ID: 24356596
[TBL] [Abstract][Full Text] [Related]
17. Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction.
Segar MW; Patel RB; Patel KV; Fudim M; DeVore AD; Martens P; Hedayati SS; Grodin JL; Tang WHW; Pandey A
JAMA Cardiol; 2021 Jan; 6(1):68-77. PubMed ID: 33206129
[TBL] [Abstract][Full Text] [Related]
18. Visit-to-Visit Variability of Hemoglobin A
Ghouse J; Skov MW; Kanters JK; Lind B; Isaksen JL; Blanche P; Haunsø S; Køber L; Svendsen JH; Olesen MS; Holst AG; Gerds TA; Nielsen JB
Diabetes Care; 2019 Jan; 42(1):134-141. PubMed ID: 30352898
[TBL] [Abstract][Full Text] [Related]
19. Body Weight Variability and the Risk of Cardiovascular Outcomes and Mortality in Patients With Type 2 Diabetes: A Nationwide Cohort Study.
Nam GE; Kim W; Han K; Lee CW; Kwon Y; Han B; Park S; Park JH; Kim YH; Kim DH; Kim SM; Choi YS; Cho KH; Park YG
Diabetes Care; 2020 Sep; 43(9):2234-2241. PubMed ID: 32641375
[TBL] [Abstract][Full Text] [Related]
20. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
